Skip to main content

Olmesartan Medoxomil and Hydrochlorothiazide

NDC 50090-5450 · A-S Medication Solutions

Generic nameOlmesartan Medoxomil and Hydrochlorothiazide
Dosage formTABLET
RouteORAL
Active ingredient(s)OLMESARTAN MEDOXOMIL, HYDROCHLOROTHIAZIDE
Strength25; 40 mg/1; mg/1
Pharmacologic classAngiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
Marketing categoryANDA

Packages

50090-5450-0 — 90 TABLET in 1 BOTTLE (50090-5450-0)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

50090-3701 — Olmesartan Medoxomil and Hydrochlorothiazide, 50090-4377 — Olmesartan Medoxomil and Hydrochlorothiazide, 50090-4447 — Losartan Potassium and Hydrochlorothiazide, 50090-4451 — Olmesartan Medoxomil, 50090-4872 — Valsartan and Hydrochlorothiazide, 50090-4993 — Losartan Potassium and Hydrochlorothiazide, 50090-5057 — Hydrochlorothiazide, 50090-5333 — Hydrochlorothiazide, 50090-5345 — Valsartan and Hydrochlorothiazide, 50090-5402 — OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE, 50090-5570 — Valsartan and Hydrochlorothiazide, 50090-5801 — triamterene and hydrochlorothiazide, 50090-5905 — Bisoprolol Fumarate and Hydrochlorothiazide, 50090-5960 — losartan potassium and hydrochlorothiazide, 50090-5962 — losartan potassium and hydrochlorothiazide, 50090-5985 — valsartan and hydrochlorothiazide, 50090-6014 — Hydrochlorothiazide, 50090-6030 — Bisoprolol Fumarate and Hydrochlorothiazide, 50090-6034 — Lisinopril and Hydrochlorothiazide Tablets, 50090-6062 — Lisinopril and Hydrochlorothiazide Tablets, +1040 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels